Allogene 治疗公司
US ˙ NasdaqGS ˙ US0197701065

介绍

本页面提供了有关 David D Chang 已知的内部交易历史的全面分析。内部人士包括公司的高管、董事或重要投资者。一般而言,基于内幕、非公开信息进行交易是非法的。这并不意味着他们在自己的公司进行任何交易都是非法的。但是,他们必须通过Form 4向美国证券交易委员会(SEC)报告所有交易。尽管存在这些限制,学术研究表明,整体而言,内部人士在自己公司中的投资表现往往优于市场。

平均交易盈利能力

“平均交易盈利能力”衡量了内部人士在过去三年中所有非计划性的公开市场买入交易的平均回报率。计算过程包括检查每笔交易,排除了作为10b5-1交易计划的一部分的交易。然后,对每笔交易在3、6和12个月的表现进行平均,以生成该笔交易最终的表现指标。然后,将所有交易的表现指标进行平均,计算出内部人士的总体平均表现指标。列表仅包含在过去两年中进行过至少三笔交易的内部人士。

如果内部人士的交易盈利能力显示为"N/A",则可能是因为该内部人士在过去三年内没有进行任何公开市场买入交易,或者他们进行的交易距离现在时间太近,无法计算出可靠的表现指标。

更新频率:每日

查看收益最高的的内幕交易者列表。

报告内部持仓的公司

美国证券交易委员会(SEC)文件显示David D Chang已报告在以下公司拥有持仓或进行了交易:

证券 职位 最新报告的持仓
US:ALLO / Allogene Therapeutics, Inc. President and CEO, Director 5,276,569
US:KITE / Kite Pharma, Inc. EVP, R&D, Chief Medical Off. 0
如何解读这些图表

以下图表显示了在David D Chang进行的每笔公开市场非计划交易后证券的股价表现。非计划交易是指没有作为10b5-1交易计划的一部分而进行的交易。股价表现以累积百分比变化的方式绘制。例如,如果一笔内部人士交易是在2019年1月1日进行的,该图表将显示该证券的每日百分比变化直至当前日期。如果在此期间股价从10美元涨至15美元,则股价的累积百分比变化将为50%。从10美元涨至20美元的价格变化将为100%,而从10美元跌至5美元的价格变化将为-50%。

最终,我们将评估内部人士的交易与股价的超额回报(正向或负向)之间的相关性,以判断内部人士是否在交易中利用内部信息获利。如果内部人士有这样的行为,我们预期看到(a)买入后的正回报,或者(b)卖出后的负回报。对于情况(a),买入图表将显示一系列向上倾斜的曲线,表示每次买入后都有正回报。对于情况(b),卖出图表将显示一系列向下倾斜的曲线,表示每次卖出后都有负回报。

然而,仅凭这一点还不足以得出结论。例如,如果公司的股价在多年内呈现非周期性上升,我们会预期所有买入后的图表都呈现向上倾斜。同样地,多年来呈现非周期性下降的股价会导致卖出后的图表也呈现向下倾斜。这两种情况的图表都不能表示内部人士在进行内幕交易。

最有力的指标是在公司股价呈极度循环波动的情况下,“买入”图表显示正向信号,而“卖出”图表显示负向趋势。这种情况强烈暗示内部人士可能根据内幕信息精确地计时进行交易,以获得财务优势。

ALLO / Allogene Therapeutics, Inc.内部人士买入 - 短期收益分析

在这一部分,我们分析了在 ALLO / Allogene Therapeutics, Inc. 中进行的每笔非计划的公开市场内部人士买入的盈利情况。这种分析有助于了解内部人士是否持续产生异常的回报,以及是否值得跟踪。该分析基于每笔交易后一年的情况,结果仅为理论值

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数
报告
价格
经调整
股数
经调整
价格
成本基础 达到最高利润的
天数
达到最高利润时的
价格
最高
利润($)
最高回报率(%)
2018-10-15 ALLO Chang David D 40,000 18.0000 40,000 18.0000 720,000 22 33.3000 612,000 85.00

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

ALLO / Allogene Therapeutics, Inc. Insider Trades
ALLO / Allogene Therapeutics, Inc.内部人士卖出 - 短期亏损分析

在这一部分,我们分析了在 ALLO / Allogene Therapeutics, Inc. 中进行的每笔非计划的公开市场内部人士卖出所达成的短期亏损规避。如果存在持续的亏损规避模式,可能表明未来的内部人士卖出交易预示着价格的下跌。该分析基于每笔交易后一年的情况,

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数
报告
价格
经调整
股数
经调整
价格
成本基础 达到最低利润的
天数
达到最低利润时的
价格
避免的
最高损失金额($)
避免的
最高损失率($)
2025-03-14 ALLO Chang David D 46,668 1.9600 46,668 1.9600 91,469 61 0.9528 -47,004 -51.39
2025-02-03 ALLO Chang David D 46,003 1.6800 46,003 1.6800 77,285
2022-03-15 ALLO Chang David D 23,648 7.6488 23,648 7.6488 180,879
2021-03-15 ALLO Chang David D 20,513 38.5741 20,513 38.5741 791,271
2020-03-16 ALLO Chang David D 18,710 19.2417 18,710 19.2417 360,012
2020-03-16 ALLO Chang David D 1,625 20.0634 1,625 20.0634 32,603

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

ALLO / Allogene Therapeutics, Inc. Insider Trades
内幕交易历史

该表格显示了由 David D Chang 进行的所有内幕交易的完整列表,这些交易已向美国证券交易委员会(SEC)披露。

备案日期 交易日期 表格 股票代码 证券 代码 10b5-1 股数 剩余股数 %
变化
每股
股价
交易
金额
剩余
金额
2025-03-18 2025-03-14 4 ALLO Allogene Therapeutics, Inc.
Common Stock
S - Sale -46,668 5,276,569 -0.88 1.96 -91,469 10,342,075
2025-02-05 2025-02-03 4 ALLO Allogene Therapeutics, Inc.
Common Stock
S - Sale -46,003 5,317,237 -0.86 1.68 -77,285 8,932,958
2025-01-28 2025-01-24 4 ALLO Allogene Therapeutics, Inc.
Common Stock
A - Award 552,174 5,363,240 11.48
2024-05-20 2024-05-16 4 ALLO Allogene Therapeutics, Inc.
Common Stock
A - Award 344,828 4,810,106 7.72 2.90 1,000,001 13,949,307
2024-03-18 2024-03-14 4 ALLO Allogene Therapeutics, Inc.
Common Stock
F - Taxes -53,393 4,465,278 -1.18 4.33 -231,192 19,334,654
2024-01-31 2024-01-25 4 ALLO Allogene Therapeutics, Inc.
Common Stock
A - Award 317,800 4,513,203 7.57
2023-03-24 2023-03-22 4 ALLO Allogene Therapeutics, Inc.
Common Stock
A - Award 1,924,464 4,193,911 84.80
2023-03-16 2023-03-14 4 ALLO Allogene Therapeutics, Inc.
Common Stock
F - Taxes -22,340 2,269,447 -0.97 5.56 -124,210 12,618,125
2022-03-25 2022-03-23 4 ALLO Allogene Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 2,195,512 2,195,512
2022-03-17 2022-03-15 4 ALLO Allogene Therapeutics, Inc.
Common Stock
S - Sale -23,648 2,289,652 -1.02 7.65 -180,879 17,513,090
2021-05-26 2021-05-24 4 ALLO Allogene Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -27,410 541,190 -4.82
2021-05-26 2021-05-24 4 ALLO Allogene Therapeutics, Inc.
Common Stock
M - Exercise 27,410 2,312,279 1.20 18.22 499,410 42,129,723
2021-04-02 2020-08-31 4/A ALLO Allogene Therapeutics, Inc.
Common Stock
G - Gift 205,778 856,044 31.65
2021-04-02 2020-08-31 4/A ALLO Allogene Therapeutics, Inc.
Common Stock
G - Gift 205,778 856,044 31.65
2021-03-30 2021-03-26 4 ALLO Allogene Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 298,836 298,836
2021-03-30 2021-03-26 4 ALLO Allogene Therapeutics, Inc.
Common Stock
A - Award 80,452 2,284,869 3.65
2021-03-17 2021-03-15 4 ALLO Allogene Therapeutics, Inc.
Common Stock
S - Sale -20,513 2,204,417 -0.92 38.57 -791,271 85,033,402
2020-04-28 2020-04-24 4 ALLO Allogene Therapeutics, Inc.
Common Stock
J - Other 9,187 2,224,101 0.41
2020-04-28 2020-04-24 4 ALLO Allogene Therapeutics, Inc.
Common Stock
J - Other X 9,198 1,201,108 0.77
2020-04-28 2020-03-18 4 ALLO Allogene Therapeutics, Inc.
Common Stock
G - Gift 428,022 650,266 192.59
2020-04-28 2020-03-18 4 ALLO Allogene Therapeutics, Inc.
Common Stock
G - Gift 428,022 650,266 192.59
2020-03-20 2020-03-18 4 ALLO Allogene Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 568,600 568,600
2020-03-18 2020-03-16 4 ALLO Allogene Therapeutics, Inc.
Common Stock
S - Sale -1,625 2,214,914 -0.07 20.06 -32,603 44,438,706
2020-03-18 2020-03-16 4 ALLO Allogene Therapeutics, Inc.
Common Stock
S - Sale -18,710 2,215,426 -0.84 19.24 -360,012 42,628,562
2020-03-11 2020-03-04 4 ALLO Allogene Therapeutics, Inc.
Common Stock
J - Other 9,391 2,234,136 0.42
2020-03-11 2020-03-04 4 ALLO Allogene Therapeutics, Inc.
Common Stock
J - Other X 9,402 1,191,910 0.80
2019-11-21 2019-11-19 4 ALLO Allogene Therapeutics, Inc.
Common Stock
J - Other 9,391 2,224,745 0.42
2019-11-21 2019-11-19 4 ALLO Allogene Therapeutics, Inc.
Common Stock
J - Other X 9,402 1,182,508 0.80
2019-10-29 2019-10-25 4 ALLO Allogene Therapeutics, Inc.
Common Stock
J - Other 9,391 2,215,354 0.43
2019-10-29 2019-10-25 4 ALLO Allogene Therapeutics, Inc.
Common Stock
J - Other X 9,402 1,173,106 0.81
2019-09-25 2019-09-23 4 ALLO Allogene Therapeutics, Inc.
Common Stock
J - Other 9,391 2,205,963 0.43
2019-09-25 2019-09-23 4 ALLO Allogene Therapeutics, Inc.
Common Stock
J - Other X 9,402 1,163,704 0.81
2019-09-09 2019-09-05 4 ALLO Allogene Therapeutics, Inc.
Common Stock
J - Other 9,391 2,195,469 0.43
2019-09-09 2019-09-05 4 ALLO Allogene Therapeutics, Inc.
Common Stock
J - Other X 9,402 1,154,302 0.82
2019-07-22 2019-07-18 4 ALLO Allogene Therapeutics, Inc.
Common Stock
J - Other 9,391 2,186,078 0.43
2019-07-22 2019-07-18 4 ALLO Allogene Therapeutics, Inc.
Common Stock
J - Other X 9,402 1,144,900 0.83
2019-07-12 2019-07-10 4 ALLO Allogene Therapeutics, Inc.
Common Stock
J - Other 6,388 2,176,687 0.29
2019-07-12 2019-06-18 4 ALLO Allogene Therapeutics, Inc.
Common Stock
J - Other X 10,154 1,135,498 0.90
2019-05-15 2019-05-13 4 ALLO Allogene Therapeutics, Inc.
Common Stock
J - Other X 11,753 1,125,344 1.06
2019-04-30 2019-04-26 4 ALLO Allogene Therapeutics, Inc.
Common Stock
J - Other X 11,753 1,113,591 1.07
2019-03-15 2019-03-13 4 ALLO Allogene Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 292,700 292,700
2019-03-15 2019-03-13 4 ALLO Allogene Therapeutics, Inc.
Common Stock
A - Award 173,000 2,168,625 8.67
2018-10-17 2018-10-15 4 ALLO Allogene Therapeutics, Inc.
Series A Convertible Preferred Stock
C - Conversion -5,704 0 -100.00
2018-10-17 2018-10-15 4 ALLO Allogene Therapeutics, Inc.
Common Stock
C - Conversion 29,946 1,101,838 2.79
2018-10-17 2018-10-15 4 ALLO Allogene Therapeutics, Inc.
Common Stock
P - Purchase 40,000 1,995,625 2.05 18.00 720,000 35,921,250
2018-10-10 3 ALLO Allogene Therapeutics, Inc.
Common Stock
6,679,186
2018-10-10 3 ALLO Allogene Therapeutics, Inc.
Common Stock
5,795,453
2018-10-10 3 ALLO Allogene Therapeutics, Inc.
Common Stock
5,571,583
2018-10-10 3 ALLO Allogene Therapeutics, Inc.
Common Stock
5,571,583
2018-10-10 3 ALLO Allogene Therapeutics, Inc.
Common Stock
6,679,186
2018-10-10 3 ALLO Allogene Therapeutics, Inc.
Common Stock
5,795,453
2018-10-10 3 ALLO Allogene Therapeutics, Inc.
Common Stock
5,571,583
2018-10-10 3 ALLO Allogene Therapeutics, Inc.
Common Stock
5,571,583
2018-10-10 3 ALLO Allogene Therapeutics, Inc.
Common Stock
6,679,186
2018-10-10 3 ALLO Allogene Therapeutics, Inc.
Common Stock
5,795,453
2018-10-10 3 ALLO Allogene Therapeutics, Inc.
Common Stock
5,571,583
2018-10-10 3 ALLO Allogene Therapeutics, Inc.
Common Stock
5,571,583
2017-10-05 2017-10-03 4 KITE Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
D - Sale to Issuer -90,600 0 -100.00
2017-10-05 2017-10-03 4 KITE Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
D - Sale to Issuer -37,181 0 -100.00
2017-10-05 2017-10-03 4 KITE Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
D - Sale to Issuer -28,919 0 -100.00 116.13 -3,358,363
2017-10-05 2017-10-03 4 KITE Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
D - Sale to Issuer -23,437 0 -100.00
2017-10-05 2017-10-03 4 KITE Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
D - Sale to Issuer -51,563 0 -100.00 128.04 -6,602,127
2017-10-05 2017-10-03 4 KITE Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
D - Sale to Issuer -56,250 0 -100.00
2017-10-05 2017-10-03 4 KITE Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
D - Sale to Issuer -116,750 0 -100.00 173.11 -20,210,592
2017-10-05 2017-10-03 4 KITE Kite Pharma, Inc.
Common Stock
D - Sale to Issuer -38,675 0 -100.00
2017-10-05 2017-10-03 4 KITE Kite Pharma, Inc.
Common Stock
U - Other -16,605 38,675 -30.04 180.00 -2,988,900 6,961,500
2017-10-05 2017-09-20 4 KITE Kite Pharma, Inc.
Common Stock
G - Gift -570 55,280 -1.02
2017-10-05 2017-09-13 4 KITE Kite Pharma, Inc.
Common Stock
G - Gift -157 55,850 -0.28
2017-10-05 2017-09-12 4 KITE Kite Pharma, Inc.
Common Stock
G - Gift -1,041 56,007 -1.82
2017-10-05 2017-09-11 4 KITE Kite Pharma, Inc.
Common Stock
G - Gift -375 57,048 -0.65
2017-09-27 2017-09-25 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale -7,927 57,423 -12.13 179.66 -1,424,196 10,316,840
2017-09-27 2017-09-25 4 KITE Kite Pharma, Inc.
Common Stock
A - Award 15,000 65,350 29.79
2017-05-03 2017-05-01 4 KITE Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
M - Exercise -20,000 123,000 -13.99
2017-05-03 2017-05-01 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -300 50,165 -0.59 83.36 -25,008 4,181,754
2017-05-03 2017-05-01 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -5,905 50,465 -10.48 82.60 -487,753 4,168,409
2017-05-03 2017-05-01 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -13,795 56,370 -19.66 81.84 -1,128,983 4,613,321
2017-05-03 2017-05-01 4 KITE Kite Pharma, Inc.
Common Stock
M - Exercise 20,000 70,165 39.87 6.89 137,800 483,437
2017-04-04 2017-04-03 4 KITE Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
M - Exercise -20,000 143,000 -12.27
2017-04-04 2017-04-03 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -700 50,165 -1.38 83.66 -58,562 4,196,804
2017-04-04 2017-04-03 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -8,697 50,865 -14.60 82.60 -718,372 4,201,449
2017-04-04 2017-04-03 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -3,549 59,562 -5.62 82.00 -291,018 4,884,084
2017-04-04 2017-04-03 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -2,424 63,111 -3.70 80.44 -194,987 5,076,649
2017-04-04 2017-04-03 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -3,939 65,535 -5.67 79.63 -313,663 5,218,552
2017-04-04 2017-04-03 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -691 69,474 -0.98 78.53 -54,264 5,455,793
2017-04-04 2017-04-03 4 KITE Kite Pharma, Inc.
Common Stock
M - Exercise 20,000 70,165 39.87 6.89 137,800 483,437
2017-03-02 2017-03-01 4 KITE Kite Pharma, Inc.
Employee Stock Option(Right to Buy)
M - Exercise -60,000 163,000 -26.91
2017-03-02 2017-03-01 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -4,735 50,165 -8.62 79.71 -377,427 3,998,652
2017-03-02 2017-03-01 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -55,265 54,900 -50.17 79.11 -4,372,014 4,343,139
2017-03-02 2017-03-01 4 KITE Kite Pharma, Inc.
Common Stock
M - Exercise 60,000 110,165 119.61 6.89 413,400 759,037
2016-12-27 2016-12-22 4 KITE Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
A - Award 90,600 90,600
2016-12-27 2016-12-22 4 KITE Kite Pharma, Inc.
Common Stock
A - Award 24,800 49,923 98.71
2016-12-22 2016-12-20 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale -1,788 25,123 -6.64 50.86 -90,938 1,277,756
2015-12-21 2015-12-17 4 KITE Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
A - Award 66,100 66,100
2015-12-21 2015-12-17 4 KITE Kite Pharma, Inc.
Common Stock
A - Award 18,500 25,404 267.96
2015-11-12 2015-11-10 4 KITE Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
M - Exercise -30,800 223,000 -12.14
2015-11-12 2015-11-10 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -30,800 6,904 -81.69 80.02 -2,464,616 552,458
2015-11-12 2015-11-10 4 KITE Kite Pharma, Inc.
Common Stock
M - Exercise 30,800 37,704 446.12 6.89 212,212 259,781
2015-11-04 2015-11-02 4 KITE Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
M - Exercise -7,700 253,800 -2.94
2015-11-04 2015-11-02 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -3,923 6,904 -36.23 71.70 -281,279 495,017
2015-11-04 2015-11-02 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -2,800 10,827 -20.55 70.96 -198,688 768,284
2015-11-04 2015-11-02 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -500 13,627 -3.54 69.52 -34,760 947,349
2015-11-04 2015-11-02 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -477 14,127 -3.27 68.27 -32,565 964,450
2015-11-04 2015-11-02 4 KITE Kite Pharma, Inc.
Common Stock
M - Exercise 7,700 14,604 111.53 6.89 53,053 100,622
2015-10-02 2015-10-01 4 KITE Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
M - Exercise -7,700 261,500 -2.86
2015-10-02 2015-10-01 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -7,700 6,904 -52.73 55.11 -424,347 380,479
2015-10-02 2015-10-01 4 KITE Kite Pharma, Inc.
Common Stock
M - Exercise 7,700 14,604 111.53 6.89 53,053 100,622
2015-09-08 2015-09-08 4 KITE Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
M - Exercise -7,384 269,200 -2.67
2015-09-08 2015-09-08 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -7,384 6,904 -51.68 55.00 -406,120 379,720
2015-09-08 2015-09-08 4 KITE Kite Pharma, Inc.
Common Stock
M - Exercise 7,384 14,288 106.95 6.89 50,876 98,444
2015-09-08 2015-09-03 4 KITE Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
M - Exercise -316 276,584 -0.11
2015-09-08 2015-09-03 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -316 6,904 -4.38 55.00 -17,380 379,720
2015-09-08 2015-09-03 4 KITE Kite Pharma, Inc.
Common Stock
M - Exercise 316 7,220 4.58 6.89 2,177 49,746
2015-08-04 2015-08-03 4 KITE Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
M - Exercise -7,700 276,900 -2.71
2015-08-04 2015-08-03 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -319 6,000 -5.05 73.87 -23,565 443,220
2015-08-04 2015-08-03 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -2,205 6,319 -25.87 72.93 -160,811 460,845
2015-08-04 2015-08-03 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -2,276 8,524 -21.07 72.29 -164,532 616,200
2015-08-04 2015-08-03 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -2,900 10,800 -21.17 71.15 -206,335 768,420
2015-08-04 2015-08-03 4 KITE Kite Pharma, Inc.
Common Stock
M - Exercise 7,700 13,700 128.33 6.89 53,053 94,393
2015-07-02 2015-07-01 4 KITE Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
M - Exercise -7,700 284,600 -2.63
2015-07-02 2015-07-01 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -1,410 6,000 -19.03 62.97 -88,788 377,820
2015-07-02 2015-07-01 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -2,896 7,410 -28.10 62.31 -180,450 461,717
2015-07-02 2015-07-01 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -3,394 10,306 -24.77 61.15 -207,543 630,212
2015-07-02 2015-07-01 4 KITE Kite Pharma, Inc.
Common Stock
M - Exercise 7,700 13,700 128.33 6.89 53,053 94,393
2015-06-17 2015-06-15 4 KITE Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
M - Exercise -7,700 292,300 -2.57
2015-06-17 2015-06-15 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -2,541 6,000 -29.75 58.04 -147,480 348,240
2015-06-17 2015-06-15 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -2,726 8,541 -24.19 56.93 -155,191 486,239
2015-06-17 2015-06-15 4 KITE Kite Pharma, Inc.
Common Stock
S - Sale X -2,433 11,267 -17.76 55.93 -136,078 630,163
2015-06-17 2015-06-15 4 KITE Kite Pharma, Inc.
Common Stock
M - Exercise 7,700 13,700 128.33 6.89 53,053 94,393
2015-06-17 2014-06-25 4 KITE Kite Pharma, Inc.
Common Stock
P - Purchase 4,000 6,000 200.00 17.00 68,000 102,000
2014-12-30 2014-12-24 4 KITE Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
A - Award 75,000 75,000
P
非衍生或衍生证券的公开市场或私下买入
S
非衍生或衍生证券的公开市场或私下卖出
A
公司向内部人员授予、奖励或以其他方式获取证券(例如股票期权)
C
衍生工具转换
D
将证券卖出或转让回公司
F
使用从公司收到的证券的一部分来支付行使价或税务负担。
G
内部人士赠送或接收他人赠送公司股票
K
股权掉期和类似的避险交易
M
行使或转换从公司获得的衍生证券(例如期权)
V
内部人士通过Form 4自愿报告的一笔交易
J
其他(附有交易描述的脚注)